{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T09:05:50Z","timestamp":1777799150438,"version":"3.51.4"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1,15]]},"DOI":"10.1097\/tp.0b013e3181fc0a35","type":"journal-article","created":{"date-parts":[[2010,12,28]],"date-time":"2010-12-28T04:23:43Z","timestamp":1293510223000},"page":"e3-e4","source":"Crossref","is-referenced-by-count":7,"title":["Effects of Plasmapheresis on Mycophenolic Acid Concentrations"],"prefix":"10.1097","volume":"91","author":[{"given":"Angela Q.","family":"Maldonado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal M.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacy A.","family":"Crow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"Little","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Okechukwu N.","family":"Ojogho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas L.","family":"Weeks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-23-20210129","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1592\/phco.27.11.1529","article-title":"Drug removal by plasmapheresis: An evidence-based review.","volume":"27","author":"Ibrahim","year":"2007","journal-title":"Pharmacotherapy"},{"key":"R2-23-20210129","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.bbmt.2005.08.037","article-title":"High unbound mycophenolic acid concentrations in a hematopoietic cell transplantation patient with sepsis and renal and hepatic dysfunction.","volume":"11","author":"Jacobsen","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"R3-23-20210129","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00007691-200408000-00017","article-title":"Severe toxicity associated with a markedly elevated mycophenolic acid free fraction in a renal transplant recipient.","volume":"26","author":"Mudge","year":"2004","journal-title":"Ther Drug Monit"},{"key":"R4-23-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/0091270008329558","article-title":"Population pharmacokinetics of mycophenolic acid and its 2 glucuronidated metabolites in kidney transplant recipients.","volume":"49","author":"Sam","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"R5-23-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.","volume":"46","author":"Staatz","year":"2007","journal-title":"Clin Pharmacokinet"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0b013e3181fc0a35","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:22:49Z","timestamp":1620976969000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201101150-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,15]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181fc0a35","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,15]]}}}